financetom
Business
financetom
/
Business
/
China's Baidu launches two new AI models as industry competition heats up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Baidu launches two new AI models as industry competition heats up
Mar 15, 2025 7:31 PM

HONG KONG, March 16 (Reuters) - China's Baidu ( BIDU )

said on Sunday it has launched two new artificial intelligence

models, the multimodal ERNIE 4.5 and a new reasoning-focused

model called X1, as it vies to stand out in a fiercely

competitive AI race.

Chinese AI startup DeepSeek's roll-out of AI models which it

says is on par with, or even better than, industry-leading

models in the United States at a fraction of the cost, has

roiled the industry and re-energised the global AI race.

Baidu's ( BIDU ) ERNIE 4.5 model has "excellent multimodal

understanding ability. It has more advanced language ability,

and its understanding, generation, logic, and memory abilities

are comprehensively improved," the company said.

It also has "high EQ", and it is easy to understand network

memes and satirical cartoons, Baidu ( BIDU ) said.

One of China's earliest tech giants to launch a

ChatGPT-style chatbot, Baidu ( BIDU ) has struggled to gain widespread

adoption for its Ernie large language model, despite claiming

performance comparable to OpenAI's GPT-4, amid fierce

competition.

Multimodal AI systems are capable of processing and

integrating various types of data including text, video, images

and audio, and can convert content across these formats.

The X1 has "stronger understanding, planning, reflection,

and evolution capabilities," Baidu ( BIDU ) said, adding that it is the

first deep thinking model that uses tools autonomously.

(Reporting by Farah Master and the Beijing newsroom; Editing by

Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jazz Pharmaceuticals Q3 revenue beats estimates
Jazz Pharmaceuticals Q3 revenue beats estimates
Nov 5, 2025
Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
Nov 5, 2025
MIAMI--(BUSINESS WIRE)-- World Kinect Corporation ( WKC ) today announced that it has completed its previously announced acquisition of the Trip Support Services (TSS) division of Universal Weather and Aviation. Universal Weather, headquartered in Houston, Texas, has been a pioneer in trip support services with deep expertise in international travel regulations, logistics, and supply chain management. Its trip support business...
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Nov 5, 2025
Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...
Delaware judge says she will not block Metsera from ending Pfizer deal 
Delaware judge says she will not block Metsera from ending Pfizer deal 
Nov 5, 2025
WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved